![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: LENG9 |
Gene summary for LENG9 |
![]() |
Gene information | Species | Human | Gene symbol | LENG9 | Gene ID | 94059 |
Gene name | leukocyte receptor cluster member 9 | |
Gene Alias | LENG9 | |
Cytomap | 19q13.42 | |
Gene Type | protein-coding | GO ID | GO:0003674 | UniProtAcc | A0A087WVD1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
94059 | LENG9 | LZE24T | Human | Esophagus | ESCC | 1.44e-13 | 3.89e-01 | 0.0596 |
94059 | LENG9 | LZE21T | Human | Esophagus | ESCC | 9.27e-04 | 2.40e-01 | 0.0655 |
94059 | LENG9 | P1T-E | Human | Esophagus | ESCC | 8.82e-20 | 9.07e-01 | 0.0875 |
94059 | LENG9 | P2T-E | Human | Esophagus | ESCC | 1.99e-07 | 1.46e-01 | 0.1177 |
94059 | LENG9 | P4T-E | Human | Esophagus | ESCC | 7.68e-05 | 8.76e-02 | 0.1323 |
94059 | LENG9 | P8T-E | Human | Esophagus | ESCC | 1.94e-15 | 2.77e-01 | 0.0889 |
94059 | LENG9 | P15T-E | Human | Esophagus | ESCC | 3.98e-05 | 1.09e-01 | 0.1149 |
94059 | LENG9 | P20T-E | Human | Esophagus | ESCC | 1.25e-03 | 1.26e-01 | 0.1124 |
94059 | LENG9 | P21T-E | Human | Esophagus | ESCC | 1.08e-05 | 1.25e-01 | 0.1617 |
94059 | LENG9 | P23T-E | Human | Esophagus | ESCC | 1.09e-13 | 3.49e-01 | 0.108 |
94059 | LENG9 | P24T-E | Human | Esophagus | ESCC | 5.06e-12 | 1.55e-01 | 0.1287 |
94059 | LENG9 | P26T-E | Human | Esophagus | ESCC | 2.85e-10 | 1.51e-01 | 0.1276 |
94059 | LENG9 | P28T-E | Human | Esophagus | ESCC | 2.06e-09 | 1.06e-01 | 0.1149 |
94059 | LENG9 | P31T-E | Human | Esophagus | ESCC | 1.37e-03 | 1.56e-01 | 0.1251 |
94059 | LENG9 | P32T-E | Human | Esophagus | ESCC | 5.74e-06 | 7.73e-02 | 0.1666 |
94059 | LENG9 | P36T-E | Human | Esophagus | ESCC | 1.09e-09 | 2.97e-01 | 0.1187 |
94059 | LENG9 | P37T-E | Human | Esophagus | ESCC | 2.21e-07 | 1.65e-01 | 0.1371 |
94059 | LENG9 | P39T-E | Human | Esophagus | ESCC | 2.18e-06 | 1.08e-01 | 0.0894 |
94059 | LENG9 | P42T-E | Human | Esophagus | ESCC | 4.69e-06 | 2.36e-01 | 0.1175 |
94059 | LENG9 | P44T-E | Human | Esophagus | ESCC | 1.73e-02 | 1.07e-01 | 0.1096 |
Page: 1 2 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![]() | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
LENG9 | SNV | Missense_Mutation | novel | c.854N>T | p.Ala285Val | p.A285V | protein_coding | tolerated(0.2) | benign(0.077) | TCGA-D6-6516-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
LENG9 | SNV | Missense_Mutation | novel | c.1324N>C | p.Glu442Gln | p.E442Q | protein_coding | tolerated(0.4) | possibly_damaging(0.801) | TCGA-MT-A67D-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
LENG9 | SNV | Missense_Mutation | novel | c.1336N>T | p.Ser446Cys | p.S446C | protein_coding | tolerated(0.06) | possibly_damaging(0.84) | TCGA-BR-8297-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | etoposide | SD | |
LENG9 | SNV | Missense_Mutation | novel | c.455N>T | p.Ala152Val | p.A152V | protein_coding | deleterious(0.01) | benign(0.232) | TCGA-CG-4442-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
LENG9 | SNV | Missense_Mutation | novel | c.567G>C | p.Lys189Asn | p.K189N | protein_coding | tolerated(0.46) | benign(0.007) | TCGA-HU-8604-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | doxifluridine | SD | |
LENG9 | deletion | Frame_Shift_Del | novel | c.761delN | p.Gly254AlafsTer52 | p.G254Afs*52 | protein_coding | TCGA-BR-4201-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Chemotherapy | cisplatin | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |